Accurate and comprehensive identification of enteropathogens, causing infectious gastroenteritis, is essential for optimal patient treatment and effective isolation processes in health care systems. Traditional diagnostic techniques are well established and optimised in low-cost formats. However, thorough testing for a wider range of causal agents is time consuming and remains limited to a subset of pathogenic organisms. Metagenomic next-generation sequencing (mNGS) allows the identification of all pathogens in a sample in a single test, without a reliance on culture or introduction of target selection bias. This study aims to determine the ability to routinely apply mNGS testing, in comparison to traditional culture or polymerase chain reaction (PCR) based tests, for the identification of causal pathogens for gastrointestinal infections. The performance of mNGS, PCR and microscopy, culture and sensitivity (MCS) assays was established using 2,619 prospectively collected faecal samples from patients with symptomology indicative of infectious gastroenteritiss. Commonly experienced pathogens including Aeromonas spp, Campylobacter spp, Salmonella spp and Giardia spp, in single and co-infected patients, were used to establish test outcomes. When testing for these organisms, using the combined result from either or both PCR and MCS testing as the comparator, the mNGS assay had clinically acceptable sensitivity (89.2-100%). Further, the mNGS assay detected 14 additional enteropathogens, that were either not detected or not tested, by initial PCR/MCS testing. The advantage of mNGS compared to other syndromic testing systems is the broad range of detectable targets and the ability to interrogate samples without clinician informed or assay specific bias. With the development of newer sequencing assays, it is now feasible to test for a wide range of target organisms in a sample using a single mNGS test. Overall, the mNGS based approach enabled pathogen detection that was comparable to conventional diagnostics and was shown to have the potential to be extended for the detection of many pathogens and genes of clinical interest. In conclusion, the mNGS assay offers an easy, sample to answer workflow with rapid detection of enteropathogens and has the potential to improve diagnosis, therapy and infection control precautions.
With the rapid development of Quantum Machine Learning, quantum neural networks (QNN) have experienced great advancement in the past few years, harnessing the advantages of quantum computing to significantly speed up classical machine learning tasks. Despite their increasing popularity, the quantum neural network is quite counter-intuitive and difficult to understand, due to their unique quantum-specific layers (e.g., data encoding and measurement) in their architecture. It prevents QNN users and researchers from effectively understanding its inner workings and exploring the model training status. To fill the research gap, we propose VIOLET , a novel visual analytics approach to improve the explainability of quantum neural networks. Guided by the design requirements distilled from the interviews with domain experts and the literature survey, we developed three visualization views: the Encoder View unveils the process of converting classical input data into quantum states, the Ansatz View reveals the temporal evolution of quantum states in the training process, and the Feature View displays the features a QNN has learned after the training process. Two novel visual designs, i.e., satellite chart and augmented heatmap, are proposed to visually explain the variational parameters and quantum circuit measurements respectively. We evaluate VIOLET through two case studies and in-depth interviews with 12 domain experts. The results demonstrate the effectiveness and usability of VIOLET in helping QNN users and developers intuitively understand and explore quantum neural networks.
Aim: To examine if fasting affects serum bilirubin levels in clinical healthy males and females.
Methods: We utilised retrospective data from phase 1 clinical trials where blood was collected in either a fed or fasting state at screening and pre-dosing time points and analysed for total bilirubin levels as per standard clinical procedures. Participants were clinically healthy males (n = 105) or females (n = 30) aged 18 to 48 inclusive who participated in a phase 1 clinical trial in 2012 or 2013.
Results: We found a statistically significant increase in total serum bilirubin levels in fasting males as compared to non-fasting males. The fasting time correlated positively with increased bilirubin levels. The age of the healthy males did not correlate with their fasting bilirubin level. We found no correlation between fasting and bilirubin levels in clinically normal females.
Conclusions: The recruitment and screening of volunteers for a clinical trial is a time-consuming and expensive process. This study clearly demonstrates that testing for serum bilirubin should be conducted on non-fasting male subjects. If fasting is required, then participants should not be excluded from a trial based on an elevated serum bilirubin that is deemed non-clinically significant.
SARS-CoV-2 variants evade immunity despite vaccination with prototype COVID-19 vaccines or previous infection. The 2019nCoV-311 (part 2) study is evaluating immune responses after two booster doses of a vaccine containing the omicron BA.5 subvariant spike protein in adults previously vaccinated with a prototype mRNA vaccine. This interim analysis reports on day 28 immunogenicity and safety outcomes after one booster dose.
In Summer 1986, the need arose for the US Air Force to develop a method for the quick, inexpensive construction of an easily hidden aircraft parking and runway system in Europe. This case history describes the experimental construction of one such parking area during a military training exercise in August 1986. This facility had to be constructed with minimal manpower and almost no equipment; it had to be sufficient to carry fully loaded A-10 aircraft. The site's soil was a light grey, gap graded, medium coarse to very fine sand, with some fine roots and organic material mixed with it. Sand was removed to 150mm depth and later replaced, to install geogrid in two layers, 75mm and 150mm below grade. At the end of installation, the sand was densified by a thorough wetting. Although only rudimentary tests could be made of the strength of the geogrid-soil parking area, the test results showed that it was adequate for support aircraft landing and taking off. For the covering abstract see IRRD 865821.